Ms Deborah Higgins | Director - RSV Vaccine Project

Ms Deborah Higgins, Director - RSV Vaccine Project, P.A.T.H.

Deborah Higgins is the Scientific Director of the RSV Vaccine Development Project in the Vaccine Development Global Program at PATH.  She has 25 years of experience in product development for infectious disease, vaccine and adjuvant applications. Prior to joining PATH, Deborah held positions at CDC, Chiron (now Novartis), Dynavax Technologies, and Neugenesis Corp. (now Intrexon), most recently managing and leading scientific vaccine development programs including HPV, anthrax, and influenza.  She was part of the team that developed the MF59 adjuvant, contributed to the development of CpG (TLR9-agonist) adjuvants, and has authored more than 25 publications on infectious disease and vaccine-related topics.

back to speakers